An update on current practices in the management of ocular toxoplasmosis

American Journal of Ophthalmology

Volumn 134, Issue 1, 2002, Pages 102-114

  Holland, Gary N ^a   Lewis, Kevan G ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; DAPSONE; DOXYCYCLINE; FANSIDAR; FOLINIC ACID; MINOCYCLINE; PREDNISONE; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE; SULFAFURAZOLE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; TRIMETREXATE; TRISULFAPYRIMIDINE; UNCLASSIFIED DRUG;

CHORIORETINITIS; CRYOTHERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; EYE INFLAMMATION; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; IMMUNE DEFICIENCY; LASER COAGULATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; OPTIC DISK; PATIENT CARE; PHYSICIAN; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; PUBLICATION; QUESTIONNAIRE; RETINA FOVEA; REVIEW; SIDE EFFECT; TOXOPLASMOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UVEITIS; VISION; VITRECTOMY;

EID: 0036298621     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01526-X     Document Type: Editorial

References (41)

1. Current practices in the management of ocular toxoplasmosis
2. Therapy for ocular toxoplasmosis
3. Azithromycin for ocular toxoplasmosis
4. Atovaquone for the treatment of Toxoplasma retinochoroiditis in immunocompetent patients
5. Behandlung der toxoplasmose-retinochoroiditis mit atovaquon bei immunokompetenten patienten
6. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis
7. Atypical, severe toxoplasmic retinochoroiditis in elderly patients
8. Ocular toxoplasmosis after the fifth decade
9. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome
10. Ocular toxoplasmosis in AIDS patients
11. Ocular toxoplasmosis in human immunodeficiency virus-infected patients
12. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial
13. Eye manifestations of congenital toxoplasmosis
14. Recurrent ocular disease in post-natally acquired toxoplasmosis
15. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis
16. Reconsidering the pathogenesis of ocular toxoplasmosis
17. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis
18. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection
19. A follow-up study of Toxoplasma gondii infection in southern Brazil
20. Ocular toxoplasmosis: New directions for clinical investigation
21. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group
22. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis
23. Quadruple therapy for ocular toxoplasmosis
24. Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection
25. Drug hypersensitivity reactions and human immunodeficiency virus disease
26. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group
27. Toxoplasmosis
28. Ocular toxoplasmosis. The XIV Jackson Memorial Lecture
29. In vivo and in vitro effects of trimethoprim and sulfamethoxazole on Toxoplasma infection
30. In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii
31. Comparative effect of trimethoprim and pyrimethamine, alone and in combination with a sulfonamide, on Toxoplasma gondii: In vitro and in vivo studies
32. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo
33. Trimethoprim-sulfamethoxazole in the United States
34. Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine
35. Ocular tissue absorption of clindamycin phosphate
36. The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice
37. Clindamycin in the treatment of toxoplasmic retinochoroiditis
38. Atovaquone: A review
39. Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy
40. Results of treatment of ocular toxoplasmosis with injectable corticosteroids
41. Fulminant ocular toxoplasmosis